Specify a stock or a cryptocurrency in the search bar to get a summary
Arctic Bioscience AS
ABSArctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand worldwide. The company was incorporated in 2011 and is headquartered in Ørsta, Norway. Address: Industrivegen 42, Ørsta, Norway, 6155
Analytics
WallStreet Target Price
109.27 NOKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ABS
Dividend Analytics ABS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABS
Stock Valuation ABS
Financials ABS
Results | 2019 | Dynamics |